These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 19004038

  • 41. Active comparator trial of teriparatide vs alendronate for treating glucocorticoid-induced osteoporosis: results from the Hispanic and non-Hispanic cohorts.
    Losada BR, Zanchetta JR, Zerbini C, Molina JF, De la Peña P, Liu CC, Smith RB, Nino AJ, Krohn K, Warner MR.
    J Clin Densitom; 2009; 12(1):63-70. PubMed ID: 19028124
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. PDN-21 in premenopausal women with systemic lupus erythematosus treated with glucocorticoids.
    Navarro MA, Formiga F, Blanco A, Bonnin MR, Nolla JM, Moga I.
    J Rheumatol; 1995 Dec; 22(12):2238-40. PubMed ID: 8835555
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [Bone mineral density in female patients with systemic lupus erythematosus treated with high glucocorticoid doses].
    Formiga F, Moga I, Navarro MA, Nolla JM, Bonnin R, Roig-Escofet D, Pujol R.
    Rev Clin Esp; 1996 Nov; 196(11):747-50. PubMed ID: 9132838
    [Abstract] [Full Text] [Related]

  • 46. [Prevention of glucocorticoid-induced osteoporosis in patients with primary glomerulonephritis].
    Chen H, Wang M.
    Zhonghua Yi Xue Za Zhi; 2005 Aug 17; 85(31):2207-10. PubMed ID: 16321186
    [Abstract] [Full Text] [Related]

  • 47. A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis.
    Hagino H, Nishizawa Y, Sone T, Morii H, Taketani Y, Nakamura T, Itabashi A, Mizunuma H, Ohashi Y, Shiraki M, Minamide T, Matsumoto T.
    Bone; 2009 Jun 17; 44(6):1078-84. PubMed ID: 19264155
    [Abstract] [Full Text] [Related]

  • 48. Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus.
    Kipen Y, Briganti E, Strauss B, Will R, Littlejohn G, Morand E.
    J Rheumatol; 1999 Feb 17; 26(2):310-7. PubMed ID: 9972964
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Self-reported fractures and associated factors in women with systemic lupus erythematosus.
    Lee C, Almagor O, Dunlop DD, Manzi S, Spies S, Ramsey-Goldman R.
    J Rheumatol; 2007 Oct 17; 34(10):2018-23. PubMed ID: 17787041
    [Abstract] [Full Text] [Related]

  • 52. Dietary calcium and bone mineral density in premenopausal women with systemic lupus erythematosus.
    Chong HC, Chee SS, Goh EM, Chow SK, Yeap SS.
    Clin Rheumatol; 2007 Feb 17; 26(2):182-5. PubMed ID: 16565892
    [Abstract] [Full Text] [Related]

  • 53. Attempted randomized controlled trial of pamidronate versus calcium and calcitriol supplements for management of steroid-induced osteoporosis in children and adolescents.
    Brown JJ, Zacharin MR.
    J Paediatr Child Health; 2005 Nov 17; 41(11):580-2. PubMed ID: 16398842
    [Abstract] [Full Text] [Related]

  • 54. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women.
    Sinigaglia L, Varenna M, Binelli L, Zucchi F, Ghiringhella D, Gallazzi M, Limonta M, Zeni S, Fantini F.
    J Rheumatol; 1999 Jun 17; 26(6):1280-4. PubMed ID: 10381043
    [Abstract] [Full Text] [Related]

  • 55. Ten-year follow-up of 3 years of oral adjuvant clodronate therapy shows significant prevention of osteoporosis in early-stage breast cancer.
    Saarto T, Vehmanen L, Blomqvist C, Elomaa I.
    J Clin Oncol; 2008 Sep 10; 26(26):4289-95. PubMed ID: 18779616
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Osteopenia in young hypogonadal women with systemic lupus erythematosus receiving chronic steroid therapy: a randomized controlled trial comparing calcitriol and hormonal replacement therapy.
    Kung AW, Chan TM, Lau CS, Wong RW, Yeung SS.
    Rheumatology (Oxford); 1999 Dec 10; 38(12):1239-44. PubMed ID: 10587552
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. The comparative study of bone mineral density between premenopausal women receiving long term suppressive doses of levothyroxine for well-differentiated thyroid cancer with healthy premenopausal women.
    Sajjinanont T, Rajchadara S, Sriassawaamorn N, Panichkul S.
    J Med Assoc Thai; 2005 Nov 10; 88 Suppl 3():S71-6. PubMed ID: 16858944
    [Abstract] [Full Text] [Related]

  • 60. [Methimazole versus methimazole and diphosphonates in hyperthyroid and osteoporotic patients].
    Lupoli GA, Fittipaldi MR, Fonderico F, Panico A, Colarusso S, Di Micco L, Cavallo A, Costa L, Paglione A, Lupoli G.
    Minerva Endocrinol; 2005 Jun 10; 30(2):89-94. PubMed ID: 15988404
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.